Prognosis of West Nile virus associated acute flaccid paralysis: a case series by Johnstone, Jennie et al.
CASE REPORT Open Access
Prognosis of West Nile virus associated acute
flaccid paralysis: a case series
Jennie Johnstone
1,2*, Steven E Hanna
3, Lindsay E Nicolle
4,5, Michael A Drebot
6, Binod Neupane
3,
James B Mahony
2,7 and Mark B Loeb
2,3,7
Abstract
Introduction: Little is known about the long-term health related quality of life outcomes in patients with West
Nile virus associated acute flaccid paralysis. We describe the quality of life scores of seven patients with acute
flaccid paralysis who presented to hospital between 2003 and 2006, and were followed for up to two years.
Case presentations: Between 2003 and 2006, 157 symptomatic patients with West Nile virus were enrolled in a
longitudinal cohort study of West Nile virus in Canada. Seven patients (4%) had acute flaccid paralysis. The first
patient was a 55-year-old man who presented with left upper extremity weakness. The second patient was a 54-
year-old man who presented with bilateral upper extremity weakness. The third patient was a 66-year-old woman
who developed bilateral upper and lower extremity weakness. The fourth patient was a 67-year-old man who
presented with right lower extremity weakness. The fifth patient was a 60-year-old woman who developed bilateral
lower extremity weakness. The sixth patient was a 71-year-old man with a history of Parkinson’s disease and acute
onset bilateral lower extremity weakness. The seventh patient was a 52-year-old man who presented with right
lower extremity weakness. All were Caucasian. Patients were followed for a mean of 1.1 years. At the end of follow-
up the mean score on the Physical Component Summary of the Short-Form 36 scale had only slightly increased to
39. In contrast, mean score on the Mental Component Summary of the Short-Form 36 scale at the end of follow-
up had normalized to 50.
Conclusion: Despite the poor physical prognosis for patients with acute flaccid paralysis, the mental health
outcomes are generally favorable.
Introduction
In 1999, West Nile virus caused an outbreak in New
York City and has since emerged as an important
human pathogen in North America [1,2]. Although
most cases of West Nile virus infection are asympto-
matic, symptomatic disease can occur and ranges from a
mild febrile illness (20% of infected individuals) to
severe illness with central nervous system involvement
(<1% of all infected cases) [3]. Classically, neurologic
manifestations included meningitis and encephalitis;
however, in 2002 the first cases of West Nile virus asso-
ciated acute flaccid paralysis were described [4,5]. Since
then, acute flaccid paralysis has become an established
complication of West Nile virus, presumed to result
from direct involvement of the anterior horn cells of the
spinal cord by the infection [6].
The prognosis of patients with West Nile virus-asso-
ciated acute flaccid paralysis is unclear. Several case ser-
ies have evaluated physical recovery over time, and the
majority of patients do not recover fully [6-11]. In one
report, approximately one-third of the patients had a
partial recovery, one-third recovered to near baseline
levels, and one-third had almost no recovery [11]. The
impact of the impaired physical function on quality of
life has not been reported for cases of acute flaccid
paralysis [12-14]. Improved understanding of the history
of this disease, including its impact on health-related
quality of life is necessary to provide information
addressing prognosis for patients at the time of
diagnosis.
We sought to describe the presenting features of seven
cases of acute flaccid paralysis enrolled in a prospective
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virus infection between 2003 and 2006 [13], and report
their long term health-related quality of life outcomes.
Acute flaccid paralysis was diagnosed if patients had a
positive West Nile virus IgM antibody capture enzyme-
linked immunosorbent assay confirmed by plaque
reduction neutralization assay [2], associated with acute
onset of limb weakness with marked progression over
48 hours and at least two of the following: asymmetric
weakness; areflexia or hyporeflexia of affected limbs;
absence of pain, paresthesia or numbness in affected
limbs; cerebrospinal fluid pleocytosis and elevated pro-
tein levels; electrodiagnostic studies consistent with
anterior horn cell process or abnormal increased signal
in the anterior gray matter on imaging. Outcome mea-
sures included the Physical Component Summary (PCS)
of the Short-Form-36, a standardized measure of physi-
cal function, and the Mental Component Summary
(MCS) of the Short Form-36 scale and were measured
at each visit [15,16]. The PCS and MCS scales correlate
highly with gold standard measures of physical function
(r = 0.85) and mental health (r = 0.87), respectively [16].
Patients were followed prospectively by trained research
nurses and evaluated at pre-specified intervals (baseline
(that is at the time of presentation), 30 days, six months,
one year and two years after presentation). If a patient
was lost to follow-up, the last recorded measure was
used. For both scales, scores range from 0 - 100 with
very high scores indicating a high level of function and
very low scores indicating substantial impairment. All
scores are standardized to the general US population
using linear transformation (mean score 50, (SD, 10))
[15,16].
Case presentations
Case one
A 55-year-old Caucasian man, with no known medical
problems presented with acute onset of left arm weak-
ness after a viral prodrome which included fever, fatigue,
nausea, vomiting and headache (Table 1). On examina-
tion he was afebrile (temperature of 36.9°C), hemodyna-
mically stable and had flaccid weakness of the left arm
that extended from his left wrist, up to his left shoulder.
Reflexes of the affected arm were absent. The remainder
of the neurological examination was unremarkable. A
lumbar puncture was not performed. The patient was
admitted to the hospital for observation and further
investigation. A contrast enhanced computed tomogra-
phy (CT) scan of his neck was unremarkable. Serum
IgM was positive for West Nile virus and the patient
was diagnosed with West Nile virus acute flaccid paraly-
sis affecting the left upper limb. He was discharged
eight days later following an uncomplicated hospital
stay. Once discharged, the patient underwent phy-
siotherapy two times a week to help improve the
strength in his left arm. The strength began to return
two months following admission to the hospital, and six
months later it had returned to baseline function. The
PCS and MCS outcomes can be found in Table 2.
Case two
A 54-year-old Caucasian man with a history of hyper-
tension and dyslipidemia developed a viral prodrome of
fatigue, rash, nausea, vomiting, diarrhea and a low grade
headache (Table 1). He presented with coffee ground
emesis to the hospital. In the emergency room he was
febrile (temperature of 39.1°C) but hemodynamically
stable. Neurological examination revealed mild left leg
weakness but he was otherwise normal. He was
admitted to the hospital for rehydration and was dis-
charged two days later. West Nile virus serum IgM per-
formed on admission was positive. Four days after
discharge, the patient was re-admitted for investigation
of progressive left leg weakness. He was afebrile (tem-
perature 36.1°C). Neurological examination revealed
markedly reduced strength in his left hip and quadriceps
and absent left knee and ankle reflexes. Sensation was
intact in his left lower limb and the remainder of the
Table 1 Presenting clinical features of 7 cases of acute flaccid paralysis
Baseline characteristics Presenting clinical features Therapeutic interventions
Case Age Sex Co-morbidity Fever Involved sites Intubation CSF WBC
(cells/μl)
CSF protein
(g/L)
PT OT Antidepressants
1 55y M None No LUE No - - Yes No No
2 54y M Hypertension Dyslipidemia No Bilateral UE No <5 <0.45 No No No
3 66y F None No Bilateral UE and LE Yes 123 1.27 Yes Yes No
4 67y M None No RLE No 189 1.04 Yes No No
5 60y F None No Bilateral LE No 32 0.77 Yes No Yes (citalopram)
6 71y M Heart failure Parkinson’s Yes Bilateral LE No <5 1.06 Yes Yes No
7 52y M None No RLE No 39 1.35 Yes No No
Abbreviations: y, year; M, male; F, female; L, left; R, right; UE, upper extremity; LE, lower extremity; CSF, cerebrospinal fluid; WBC, white blood cell count; PT,
physiotherapy; OT, occupational therapy.
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ture was normal (<5 white blood cells/μLa n dp r o t e i n
<0.45 g/L in the cerebrospinal fluid (CSF)). Electromyo-
graphy (EMG) findings were in keeping with peripheral
nerve demyelination with some element of neuronal
injury. A diagnosis of West Nile virus acute flaccid
paralysis was made and he was discharged home 24
hours later; by the time of discharge the left leg weak-
ness had progressed to include foot drop. Over the first
few months following discharge the left hip and quadri-
ceps weakness improved but the foot drop persisted.
The patient still had persistent foot drop at the end of
the study. The PCS and MCS outcomes can be found in
Table 2.
Case three
A 66-year-old Caucasian woman with no known medical
problems was admitted with a two-day history of fever,
headache, neck stiffness and photophobia (Table 1). She
was brought to the hospital when she developed rapidly
progressive bilateral upper and lower extremity weak-
ness. In the emergency room her temperature was 37.7°
C, her pulse was 98 beats/minute and her blood pres-
sure was 180/78 mmHg. She was intubated to protect
her airway and she had complete flaccid paralysis of
bilateral upper and lower extremities. Lumbar puncture
revealed 123 white blood cells/μL and protein of 1.27 g/
L in the CSF. Serum IgM was positive for West Nile
virus and a diagnosis of West Nile virus acute flaccid
paralysis was made. While in the intensive care unit she
was unable to be weaned from the ventilator due to
ongoing weakness and required a tracheostomy. After
one year, she had some improvement in strength in her
limbs but required ongoing ventilatory support. The
PCS and MCS outcomes can be found in Table 2.
Case four
A 67-year-old previously healthy Caucasian man with
acute onset right lower leg weakness one week following
a viral prodrome of fever, headache, myalgias and
photophobia (Table 1) presented to the hospital. In the
emergency room he was afebrile (temperature of 36.5°C)
and hemodynamically stable. Neurological examination
revealed flaccid paralysis of the right leg and absent
patellar and ankle reflexes. The remainder of his neuro-
logical examination was normal. Lumbar puncture was
abnormal with 189 white blood cells/μLa n d1 . 0g / Lo f
protein in the CSF. He was admitted to the hospital for
observation and further examination. Serum IgM was
positive for West Nile virus and an EMG was consistent
with West Nile virus acute flaccid paralysis. He was dis-
charged home after a 14-day stay. Once discharged, the
patient underwent regular physiotherapy to help
improve the strength in his leg. Although the strength
improved with time, he continued to have significant
weakness at the end of follow-up. The PCS and MCS
outcomes can be found in Table 2.
Case five
A 60-year-old previously well Caucasian woman with
acute onset bilateral lower extremity weakness after a
viral prodrome which included headache, fatigue,
malaise and myalgias presented to the hospital (Table
1). Physical examination of the lower extremities
revealed marked weakness of the right hip flexors, mild
weakness of the left hip flexors with better distal
strength bilaterally. Patellar reflexes were absent bilater-
ally but the ankle reflexes were intact. Sensation was
normal and the remainder of the neurological examina-
tion was normal. A lumbar puncture was abnormal with
32 white blood cells/μL and 0.77 g/L of protein in the
CSF. The patient was admitted for observation and
further examination. An MRI scan showed diffuse
enhancement of the cauda equina and nerve roots of
the lumbosacral spine. Serum IgM was positive for West
Nile virus and EMG was consistent with multiple root
inflammation of the cauda equina, thus a diagnosis of
West Nile virus acute flaccid paralysis was made. The
patient was discharged home after 10 days in the hospi-
tal. Following discharge she received physiotherapy. Her
Table 2 PCS and MCS outcomes
Case PCS Scores MCS Score
Baseline 30-day 6 month 1 year 2 year Change in score
† Baseline 30-day 6 month 1 year 2 year Change in score
†
1 31 34 59 - - 28 30 55 62 - - 32
2 18 58 55 59 49 31 43 58 58 57 56 13
3* -- -2 8 - - -- -3 3 - -
4 45 29 41 42 - -3 43 49 62 63 - 20
5 29 38 37 - - 8 33 39 34 - - 1
6 57 39 28 24 24 -33 12 22 37 53 50 38
7 26 32 36 - - 10 41 55 54 - - 13
*The first three measurements were not obtained as the patient was ventilated and sedated in ICU.
†Score at the end of follow-up minus the score at baseline.
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up she still required a walker for ambulation. Her PCS
and MCS outcomes can be found in Table 2.
Case six
A 71-year-old Caucasian man with a known history of
heart failure and Parkinson’s disease with rapidly pro-
gressive bilateral lower extremity weakness following a
viral prodrome of fever, rash, neck stiffness, fatigue and
myalgias (Table 1) presented to the hospital. In the
emergency room he was febrile (temperature of 39.7°C)
but hemodynamically stable. He was not oriented to
time or place. He had flaccid paralysis of his lower
extremities bilaterally and absent patellar and ankle
reflexes. Neurological examination of his upper extremi-
ties showed increased tone and tremor consistent with
the diagnosis of Parkinson’s disease. Lumbar puncture
r e s u l t sw e r ea b n o r m a l ;t h e r ew e r en ow h i t eb l o o dc e l l s
(<5 cells/μL) in the CSF but the protein was elevated at
1.06 g/L. He was admitted to the hospital for observa-
tion and further examination. Serum IgM was positive
for West Nile virus and a diagnosis of West Nile virus
acute flaccid paralysis was made. The delirium quickly
cleared and after one week in the hospital, his strength
began to return. After one month in the hospital his
strength continued to improve but was not at baseline,
thus he was transferred to an in-patient rehabilitation
facility. Although his strength ultimately returned to
baseline, his overall mobility declined with time due to
his Parkinson’s disease. His PCS and MCS outcomes
can be found in Table 2.
Case seven
A 52-year-old Caucasian man with no known medical
problems presented with acute onset of right leg weak-
ness following a viral prodrome of fever, headache, neck
stiffness, nausea, vomiting, myalgia and fatigue (Table
1). On examination he was afebrile (temperature of
35.9°C), hemodynamically stable and had flaccid weak-
ness of the entire right lower leg. Reflexes of the
affected knee and ankle were absent. The remainder of
the neurological examination was unremarkable. A lum-
bar puncture was abnormal with 39 white blood cells/
μL and 1.35 g/L protein in the CSF. He was admitted to
the hospital for observation and further examination.
An MRI scan of the spine was unremarkable. An EMG
revealed denervation in the right adductor longus mus-
cle. Serum IgM was positive for West Nile virus and the
patient was diagnosed with West Nile virus acute flaccid
paralysis affecting the right lower limb. He was dis-
charged nine days later following an uncomplicated hos-
pital stay. Once discharged, he underwent physiotherapy
two times a week. His strength began to return 10 days
following admission to the hospital, and six months
later it had almost returned to his baseline function.
The PCS and MCS outcomes can be found in Table 2.
Summary of Cases
The mean age of those with acute flaccid paralysis was
61 years [SD, 7]. Most patients with acute flaccid paraly-
sis were men (71%) and all were Caucasian. Almost one-
third (28%) of patients with acute flaccid paralysis had
any underlying co-morbidity. All patients with acute
flaccid paralysis presented with acute onset, within 48
hours, of extremity weakness. A single extremity was
involved in three patients and three patients had bilat-
eral upper or lower limb involvement. One patient had
complete flaccid paralysis of both upper and lower
extremities; this patient required intubation and pro-
l o n g e di n t e n s i v ec a r eu n i ta d m i s s i o nb e c a u s eo fr e s p i r a -
tory failure. No other patients required an intensive care
unit admission. Length of hospital stay in an acute care
facility ranged from 0 to 333 days (median 11 days). No
patient died during the follow-up period.
Patients with acute flaccid paralysis were followed for
a mean of 1.1 years [SD, 0.68]. The PCS and MCS
scores of patients with acute flaccid paralysis from each
visit can be found in Table 2. The mean PCS score at
presentation was 34 [SD, 14] and the mean MCS score
was 34 [SD, 12]. At the end of follow-up, the mean PCS
score had only slightly increased to 39 [SD, 12] whereas
the mean MCS score had normalized to 50 [SD, 12].
Patient number six appeared to be an outlier as his PCS
score decreased over time; this might be explained by
his history of Parkinson’s disease which could confound
the results. As a sensitivity analysis, the mean PCS and
MCS scores were recalculated without Patient number
six’s data and the scores were as follows: the mean PCS
score at baseline was 30 [SD, 10] and increased to 42
[SD, 11] at the end of follow-up whereas the mean MCS
score at baseline was 38 [SD, 6] and increased to 50
[SD, 13] at the end of follow-up.
The change in score over time was also calculated
(Table 2). A change score was only possible for six
patients as a baseline score was not available for Patient
number three. The mean PCS change score was 7 [SD,
23] and the mean MCS change score was 20 [SD, 14].
When the scores for Patient number six were excluded
from the analysis, the mean PCS change score was 15
[SD, 14] and the mean MCS change score was 16 [SD,
11].
Discussion
Acute flaccid paralysis affected 4% of all subjects with
infection in this cohort, and most cases occurred in
healthy adults. The incidence of West Nile virus acute
flaccid paralysis in the general population has been esti-
mated at four out of 100,000 during epidemics [9].
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<1% of all West Nile virus infections [3] and acute flac-
cid paralysis is thought to cause 5% to 10% of all cases
of neuroinvasive disease [9]. Clear risk factors for acute
flaccid paralysis have not been reported. Contrary to
other forms of West Nile virus neuroinvasive disease,
most cases of acute flaccid paralysis occur in healthy,
non-elderly individuals [9,17,18], although advanced age
m a yb ea s s o c i a t e dw i t ha ni n c reased risk of mortality
[6]. In our case series, five of the seven patients with
acute flaccid paralysis had no known co-morbidity and
the mean age was less than 65 years, reinforcing pre-
vious observations.
After a mean follow-up of 1.1 years, the physical
recovery was poor; however the mental health outcomes
appeared to be generally favorable. The poor physical
outcome seen in patients with acute flaccid paralysis is
consistent with the incomplete physical recovery seen in
this patient population [6,9]. Persistent deficits reflect
the pathophysiology, as the damage to the anterior horn
cells of the spinal cord appears to be irreversible [6].
The relative recovery of mental health outcomes was
unexpected. Normalization of the MCS scores for West
Nile fever and meningoencephalitis has been seen in a
previous study [12], but to the best of our knowledge,
this has not been documented in patients with acute
flaccid paralysis. The relative recovery of mental health
outcomes is encouraging and may help when discussing
prognosis.
The patient with Parkinson’s disease may have con-
founded the results and led to an underestimate of
improvement in mean PCS scores, but in a sensitivity
analysis the exclusion of this patient had little effect on
the MCS scores. In addition, we could not rule out the
possibility that some of the patients in this case series
also had concomitant non-severe encephalitis which
could bias the results towards underestimating
improvement.
Conclusion
Acute flaccid paralysis is an uncommon but serious
manifestation of West Nile virus infection. It should be
suspected in any individual, regardless of age or co-mor-
bidity, who presents with weakness following potential
exposure to mosquitoes. Most individuals will not
recover full physical function, but mental health out-
comes appear to recover and are comparable to those
seen with other forms of symptomatic West Nile virus
infection. Although this study is limited by the small
number of cases, there is currently a paucity of data
describing the long-term quality of life outcomes of this
rare disease, and these hypothesis-generating results
provide a foundation for future studies designed to
describe the prognosis of patients with West Nile virus
associated acute flaccid paralysis.
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